316 related articles for article (PubMed ID: 22479580)
41. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
[TBL] [Abstract][Full Text] [Related]
42. An alternative method for the analysis of melanin production in Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato.
Brilhante RSN; España JDA; de Alencar LP; Pereira VS; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Rocha MFG
Mycoses; 2017 Oct; 60(10):697-702. PubMed ID: 28699287
[TBL] [Abstract][Full Text] [Related]
43. Pigment production on L-tryptophan medium by Cryptococcus gattii and Cryptococcus neoformans.
Chaskes S; Cammer M; Nieves E; Casadevall A
PLoS One; 2014; 9(4):e91901. PubMed ID: 24736553
[TBL] [Abstract][Full Text] [Related]
44. [Mechanism of Cryptococcus Meningoencephalitis].
Miyazato A
Med Mycol J; 2016; 57(1):J27-32. PubMed ID: 26936349
[TBL] [Abstract][Full Text] [Related]
45. Molecular epidemiological investigation of
Omura M; Satoh K; Tamura T; Komori A; Makimura K
Microbiol Spectr; 2024 Apr; 12(4):e0290323. PubMed ID: 38411053
[No Abstract] [Full Text] [Related]
46. The Cryptococcus gattii species complex: Unique pathogenic yeasts with understudied virulence mechanisms.
Saidykhan L; Onyishi CU; May RC
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010916. PubMed ID: 36520688
[TBL] [Abstract][Full Text] [Related]
47. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
Kwon-Chung KJ; Fraser JA; Doering TL; Wang Z; Janbon G; Idnurm A; Bahn YS
Cold Spring Harb Perspect Med; 2014 Jul; 4(7):a019760. PubMed ID: 24985132
[TBL] [Abstract][Full Text] [Related]
48. Genotypic and Phenotypic Stability of Mixed Primary Isolates of
Nascimento CRSD; Souto ADSS; Galvão RM; Lazéra MDS; Trilles L
Biopreserv Biobank; 2020 Jun; 18(3):196-203. PubMed ID: 32213084
[TBL] [Abstract][Full Text] [Related]
49. [CAP59 gene amplification in Cryptococcus neoformans and Cryptococcus gattii directly from a yeast suspension].
Siachoque N; Jewtuchowicz VM; Iovannitti C; Mujica MT
Rev Argent Microbiol; 2010; 42(2):91-4. PubMed ID: 20589327
[TBL] [Abstract][Full Text] [Related]
50. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
51. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
Feng X; Yao Z; Ren D; Liao W; Wu J
FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
[TBL] [Abstract][Full Text] [Related]
52. Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings.
Ogundeji AO; Albertyn J; Pohl CH; Sebolai OM
J Clin Pathol; 2016 Apr; 69(4):352-7. PubMed ID: 26598625
[TBL] [Abstract][Full Text] [Related]
53. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
[TBL] [Abstract][Full Text] [Related]
54. Use of D-proline assimilation and CGB medium for screening Brazilian Cryptococcus neoformans isolates.
Nishikawa MM; Sant'Anna OD; Lazera MS; Wanke B
J Med Vet Mycol; 1996; 34(5):365-6. PubMed ID: 8912173
[TBL] [Abstract][Full Text] [Related]
55. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
Lee GA; Arthur I; Merritt A; Leung M
Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
[TBL] [Abstract][Full Text] [Related]
56. Zap1 regulates zinc homeostasis and modulates virulence in Cryptococcus gattii.
Schneider Rde O; Fogaça Nde S; Kmetzsch L; Schrank A; Vainstein MH; Staats CC
PLoS One; 2012; 7(8):e43773. PubMed ID: 22916306
[TBL] [Abstract][Full Text] [Related]
57. Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Kassi FK; Bellet V; Drakulovski P; Krasteva D; Roger F; Valérie BA; Aboubakar T; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Yavo W; Menan HIE; Bertout S
J Med Microbiol; 2018 Jan; 67(1):87-96. PubMed ID: 29214970
[TBL] [Abstract][Full Text] [Related]
58. Etiological factors of cryptococcosis - what makes them pathogens ?
Dylag M
Med Dosw Mikrobiol; 2015; 67(3-4):221-31. PubMed ID: 27019916
[TBL] [Abstract][Full Text] [Related]
59. Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe.
Cogliati M; Puccianti E; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Rickerts V; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencà ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Boekhout T; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Colom MF
Environ Microbiol; 2017 Oct; 19(10):4318-4325. PubMed ID: 28892309
[TBL] [Abstract][Full Text] [Related]
60. Heteroresistance of Cryptococcus gattii to fluconazole.
Varma A; Kwon-Chung KJ
Antimicrob Agents Chemother; 2010 Jun; 54(6):2303-11. PubMed ID: 20385871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
